Related Experiment Video
Updated: Jan 20, 2026

Author Spotlight: Enhanced Method for Evaluating Analgesic Effects — Dual Hind Paw Carrageenan Injection in Mice
Published on: November 15, 2024
[Teratogenic study of Spirulina in mice]
1Escuela Nacional de Ciencias Biológicas Instituto Politécnico Nacional (IPN) México D.F., México.
This study evaluated whether consuming the blue-green algae Spirulina during pregnancy causes harm to developing embryos or fetuses in mice. Researchers fed pregnant mice various amounts of the algae and examined the offspring for growth issues or physical defects. The findings showed no evidence of developmental toxicity or birth defects, even at high doses. This suggests that Spirulina consumption at these levels is unlikely to pose reproductive risks in this model.
Area of Science:
- Toxicology and developmental biology research involving Spirulina
- Reproductive health and safety assessment within pharmacology
Background:
No prior work had resolved whether high intake of specific blue-green algae impacts prenatal development. That uncertainty drove researchers to examine potential risks during gestation. Prior research has shown that nutritional supplements are frequently consumed by pregnant individuals globally. However, comprehensive safety data regarding developmental toxicity for this particular organism remained limited. This gap motivated a controlled investigation into maternal dietary exposure. Scientists needed to determine if elevated concentrations might interfere with normal fetal maturation. Previous studies often focused on adult health rather than reproductive outcomes. Establishing a safety profile for this dietary component is necessary for informed public health guidance.
Purpose Of The Study:
The study aimed to investigate the embryotoxic and fetotoxic potential of this specific algae in pregnant mice. Researchers sought to determine if maternal dietary intake could negatively impact developing offspring. The motivation stemmed from the need to establish safety profiles for common nutritional supplements during gestation. No prior work had resolved the specific developmental risks associated with high-dose consumption of this organism. The team designed the experiment to test whether elevated concentrations might cause physical malformations or fetal loss. By using a range of dietary levels, they intended to identify any dose-dependent adverse effects. This investigation addressed the uncertainty surrounding the safety of such supplements for pregnant populations. The authors focused on providing empirical evidence to guide future dietary recommendations for expectant mothers.
Main Methods:
Review approach involved a controlled feeding trial using pregnant mice to assess developmental safety. Investigators administered the algae at concentrations of 0, 10, 20, and 30 grams per 100 grams of diet. The team organized the exposure across three distinct gestational windows: days 7-13, 1-13, and 1-19. On day 19, researchers performed surgical procedures to harvest and evaluate the uterine contents. The protocol required counting live, dead, and resorbed fetuses to establish baseline reproductive health. Scientists weighed all surviving offspring to identify potential growth retardation or developmental delays. Each fetus underwent a thorough inspection for external, skeletal, or visceral abnormalities. The litter served as the primary unit of analysis to ensure statistical accuracy across all experimental groups.
Main Results:
Key findings from the literature demonstrate that no significant differences existed in the number of resorbed or malformed fetuses among the groups. The data showed that dietary levels up to 30 grams per 100 grams did not evoke any signs of embryotoxic effects. Researchers observed no evidence of skeletal or visceral abnormalities in the offspring of the treated mice. The total number of affected fetuses remained comparable between the control and the highest dosage groups. These results confirm that maternal exposure did not negatively influence fetal survival or physical development. The study found that even at exaggerated levels, the algae did not impair prenatal growth. No statistical variance was detected in the weight of live fetuses across the different dietary conditions. The findings consistently indicate a lack of developmental toxicity under the experimental parameters described.
Conclusions:
Synthesis and implications suggest that dietary intake of this algae does not trigger adverse reproductive outcomes. The authors propose that these findings support a lack of developmental toxicity within the tested parameters. Their data indicate that even high concentrations do not cause structural abnormalities in offspring. These results imply that maternal consumption at these levels remains safe for fetal development. The researchers highlight that their dosage levels exceed typical human intake patterns significantly. This review of the evidence confirms that no significant differences occurred in fetal resorption rates. The study provides a basis for evaluating safety margins regarding prenatal exposure. Future assessments should continue monitoring these specific biological markers to ensure ongoing reproductive safety.
Frequently Asked Questions
The researchers observed no significant differences in the number of resorbed or malformed fetuses between the control and experimental groups. This indicates that the algae did not induce embryotoxic or fetotoxic effects in the mouse model.
The study utilized pregnant mice as the experimental model, administering the algae at dietary levels of 0, 10, 20, and 30 grams per 100 grams of feed. These doses were chosen to represent significant exaggerations over standard human consumption.
The researchers administered the substance during three distinct windows of gestation: days 7-13, 1-13, and 1-19. These periods were necessary to cover the critical phases of organogenesis and overall fetal development.
The investigators examined the uterine horns on day 19 to count live, dead, and resorbed fetuses. They also weighed live offspring and performed detailed inspections for external, skeletal, and visceral malformations to ensure comprehensive safety screening.
The team measured the total number of affected fetuses per litter to determine statistical significance. This approach allowed for a robust comparison between the various dosage groups and the control group.
The authors suggest that because the tested levels were exaggerated compared to human intake, the substance does not pose a risk for prenatal harm. They conclude that the algae is safe for consumption at these high dietary concentrations.
Related Concept Videos
03:20Studying Chronic Exposure of Mice to Ultraviolet B Radiation
06:54A Modified Inflammatory Pain Model to Study the Analgesic Effect in Mice
07:17Studying Orthodontic Tooth Movement in Mice
10:36Probiotic Studies in Neonatal Mice Using Gavage
07:29Zebrafish as a Model to Assess the Teratogenic Potential of Nitrite
Teratogenicity
